|
Volume 271,
Number 18,
Issue of May 3, 1996 pp. 10640-10647
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
The
Conformational Properties of the Highly Selective Cannabinoid Receptor
Ligand CP-55,940
(Received for publication, October 16, 1995; and in revised form, February 12, 1996)
Xiang-Qun
Xie
, ,
Lawrence S.
Melvin
,
Alexandros
Makriyannis
During a search for novel drugs possessing analgesic properties
but devoid of the psychotropic effects of marijuana, a group of
molecules designated as nonclassical cannabinoids was synthesized by
Pfizer. Of these nonclassical cannabinoids CP-55,940 has received the
most attention principally because it was used as the high affinity
radioligand during the discovery and characterization of the
G-protein-coupled cannabinoid receptor. In an effort to obtain
information on the stereoelectronic requirements at the cannabinoid
receptor active site, we have studied the conformational properties of
CP-55,940 using a combination of solution NMR and computer modeling
methods. Our data show that for the most energetically favored
conformation, (i) the aromatic phenol ring is perpendicular to the
cyclohexane ring, and the phenolic O-H bond is coplanar with the
aromatic ring and points away from the cyclohexyl ring; ii) the
dimethylheptyl chain adopts one of four preferred conformations in all
of which the chain is almost perpendicular to the phenol ring; and iii)
an intramolecular H-bond between the phenolic and hydroxypropyl groups
allows all three hydroxyl groups of CP-55,940 to be oriented toward the
upper face of the molecule. Such an orientation by the OH groups may be
a characteristic requirement for cannabimimetic activity.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Kapur, D. P. Hurst, D. Fleischer, R. Whitnell, G. A. Thakur, A. Makriyannis, P. H. Reggio, and M. E. Abood
Mutation Studies of Ser7.39 and Ser2.60 in the Human CB1 Cannabinoid Receptor: Evidence for a Serine-Induced Bend in CB1 Transmembrane Helix 7
Mol. Pharmacol.,
June 1, 2007;
71(6):
1512 - 1524.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. C. Felder, A. K. Dickason-Chesterfield, and S. A. Moore
Cannabinoids Biology: The Search for New Therapeutic Targets
Mol. Interv.,
June 1, 2006;
6(3):
149 - 161.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Tian, J. Guo, F. Yao, D.-P. Yang, and A. Makriyannis
The Conformation, Location, and Dynamic Properties of the Endocannabinoid Ligand Anandamide in a Membrane Bilayer
J. Biol. Chem.,
August 19, 2005;
280(33):
29788 - 29795.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Tao, S. D. McAllister, J. Andreassi, K. W. Nowell, G. A. Cabral, D. P. Hurst, K. Bachtel, M. C. Ekman, P. H. Reggio, and M. E. Abood
Role of a Conserved Lysine Residue in the Peripheral Cannabinoid Receptor (CB2): Evidence for Subtype Specificity
Mol. Pharmacol.,
March 1, 1999;
55(3):
605 - 613.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|